Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder
NCT: NCT07045584 · COMPLETED
Brief Summary
The goal of this open-label randomized controlledl trial is to explore the safety and efficacy of conventional transcranial alternating current stimulation (tACS) and transcranial temporal interference stimulation (tTIS) targeting the temporal pole in children with autism spectrum disorder (ASD) in China. The main questions it aims to answer are: \*Can tACS and tTIS safely and effectively improve clinical symptoms in children with autism? Researchers will compare the tACS group and tTIS group with control group to explore the safety, feasibility and efficacy of the transcranial electrical stimulation in children with autism. Participants will: * tACS group: undergo 5 days of temporal pole tACS * tTIS group:undergo 5 days of temporal pole tTIS * Control group: receive routine rehabilitation training during the study period. From baseline to 4 weeks after intervention completion, subjects will be followed up regarding clinical symptoms and adverse reactions: * Safety Outcome Measures: adverse events * Primary Efficacy Outcome Measures: Social Responsiveness Scale (SRS-2) total scores * Other clinical outcome measures related language, adapative function and cognition
Frequently Asked Questions
What is Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder?
Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder is a clinical trial registered under NCT07045584. Current status: COMPLETED.
What is the status of NCT07045584?
The current status of NCT07045584 (Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder) is: COMPLETED.
When did Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder start?
Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder started on 2025-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.